SUSTAINED RELEASE TRAPIDIL PHARMACEUTICAL

Title:

SUSTAINED RELEASE TRAPIDIL PHARMACEUTICAL

Document Type and Number:

Japanese Patent JPH0753379

Kind Code:

A

Abstract:

PURPOSE: To provide a pharmaceutical moderately controllable in the releasing rate of trapidil, also perfect in its release.

CONSTITUTION: The objective sustained release trapidil pharmaceutical is characterized by coating a trapidil-contg. composition with double films respectively containing polymers differing in solubility in water from each other.

More Like This:

JP7465861	Optimized dosing of diaminophenothiazines in populations
JP2022516619	Co-administration of inhibitors to produce insulin-producing intestinal cells
JPWO2007007656	Pharmaceutical composition containing thiazolidinedione compound

Inventors:

ONO KENJI
OKADA MINORU
KASAI SHUICHI
IWASA AKIRA

Application Number:

JP20407393A

Publication Date:

February 28, 1995

Filing Date:

August 18, 1993

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SS PHARMACEUTICAL CO

International Classes:

A61K9/20; A61K9/50; A61K31/505; A61P9/08; A61P25/28; (IPC1-7): A61K31/505; A61K9/20; A61K9/50; A61K31/505

Attorney, Agent or Firm:

Miyuki Ariga (3 outside)

Next Patent: THERAPEUTIC AGENT FOR HYPERLIPEMIA AND HYPERURICEMIA